Author Contributions: Dr Farzaneh-Far had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Farzaneh-Far, Epel, Whooley.
Acquisition of data: Farzaneh-Far, Lin, Epel, Harris, Whooley.
Analysis and interpretation of data: Farzaneh-Far, Lin, Epel, Harris, Blackburn, Whooley.
Drafting of the manuscript: Farzaneh-Far.
Critical revision of the manuscript for important intellectual content: Lin, Epel, Harris, Blackburn, Whooley.
Statistical analysis: Farzaneh-Far, Lin.
Obtained funding: Farzaneh-Far, Whooley.
Administrative, technical, or material support: Lin, Epel, Harris, Blackburn, Whooley.
Study supervision: Farzaneh-Far, Whooley.
Financial Disclosures: Dr Harris reports that he is an advisor to, a speaker for, and has received research grants from companies with interests in omega-3 fatty acids, including GlaxoSmithKline and Monsanto. In addition, he has recently founded a company (OmegaQuant Analytics) to offer blood omega-3 fatty acid testing. No other disclosures were reported.
Funding/Support: Dr Farzaneh-Far is supported by an American Heart Association Fellow-to-Faculty Transition Award (grant 0875014N). The Heart and Soul Study was supported by the Department of Veterans Affairs (Epidemiology Merit Review Program), the National Heart, Lung, and Blood Institute (grant R01 HL079235), the Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program), the American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program), the Ischemia Research and Education Foundation, and the Nancy Kirwan Heart Research Fund. Dr Lin is supported by the Bernard and Barbro Foundation.
Role of the Sponsor: The funding organizations had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.